Developing as a promising development in the fight against obesity, this medication is generating considerable buzz. This treatment combines properties of two established GLP-1 receptor agonists, liraglutide, plus an unique glucose-dependent peptide component. Preliminary study findings have indicated impressive weight loss in patients with excess